Skip to main content
Contact Us
Sign Up
Subscriber Sign In
navigation
サイト内検索
COVID-19
COVID-19 Update
COVID-19 EventAnalyzer
Evaluate Vantage COVID-19 Report
COVID-19 Stories from Evaluate Vantage
Evaluate’s Business Continuity Plan
What We Do
Commercial Intelligence
Products
EvaluatePharma
EvaluatePharma Vision
European Drug Forecasts
Epi Analyzer
Evaluate Custom Solutions
Evaluate Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
Editorial Team
About Evaluate Vantage
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Evaluate Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
Covid-19
Covid-19 Coverage
Evaluate Vantage COVID-19 Report
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Pharmion
September 18, 2013
On a wing and a prayer, Clovis calls the top
July 12, 2011
Tough IPO scene continues in first half 2011
March 22, 2011
Therapeutic focus – Cephalon buy points to rare win in small cell lung cancer
January 26, 2010
Poniard's happy talk masks dire future for picoplatin
December 03, 2009
EP Vantage Interview – Clovis up and running and seeking more deals
November 24, 2009
Clavis calls on experience of newcomer Clovis in cancer deal
February 05, 2009
Allos blood cancer data hastens drug filing
June 20, 2008
Surprises in the industry's most profitable companies
May 02, 2008
Who might be on Merck's shopping list?
February 08, 2008
Pharmion shareholder raises the stakes
November 20, 2007
Celgene move on Pharmion consolidates position in blood disorders, cancer
Load More
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
July 29, 2020
Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2020
April 16, 2020
Evaluate Vantage COVID-19 Report
Editor's Picks
September 11, 2020
Esmo 2020 preview – late-breaking immunotherapy
September 11, 2020
Esmo 2020 preview – a kidney cancer showdown gets star billing
September 07, 2020
Big pharma spinouts grow up
September 09, 2020
Covid vaccine developers face nervous wait
September 03, 2020
Medtechs that book the most sales per employee face the greatest losses
